Metabolic syndrome: An all or none or a continuum load of risk?

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 1, 2012, Pages 14-19

  Cubeddu, Luigi X ^a,b   Hoffmann, Irene S ^b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LATIN AMERICAN MEDICINE; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INSULIN; LIPIDS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENEZUELA; WAIST CIRCUMFERENCE;

EID: 84856055467     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0058     Document Type: Article

References (17)

1. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva: World Health Organization, 1999.
2. National Cholesterol Education Program. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of the High Blood Cholesterol in Adults (ATP III). JAMA 2001;285:2486-2497.
3. International Diabetes federation. The IDF Consensus worldwide definitions of the metabolic syndrome, 2005 and 2007. Available at www.idf.org/webdata/docs/IDFMeta- def-final.pdf/. Accessed October 1, 2011.
4. Grundy S, Cleeman J, Daniels S et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735-2752. (Pubitemid 41532612)
5. Haffner SM, Valdez RA, Hazuda HP et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
6. Liese AD, Mayer-Davis EJ, Tyroler HA et al. Development of the multiple metabolic syndromes in the ARIC cohort: Joint contribution of insulin, BMI, and WHR: Atherosclerosis Risk in Communities. Ann Epidemiol 1997;7:407-416. (Pubitemid 27355789)
7. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
8. Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation 2004;110:1245-1250. (Pubitemid 39202340)
9. Hunt KJ, Resendez MA, Williams K et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251-1257. (Pubitemid 39202341)
10. Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414. (Pubitemid 46135879)
11. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119: 812-819. (Pubitemid 44415613)
12. Mottillo S, Filion KB, Genest J et al. metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132.
13. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal. Diabetes Care 2005;28: 2289-2304.
14. McNeill AM, Rosamond WD, Girman CJ et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerotic Risk In Communities Study. Diabetes Care 2003;28:385-390.
15. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as predictor of coronary heart disease and diabetes in the West Scotland Coronary Prevention Study. Circulation 2003;108:414-419. (Pubitemid 36935533)
16. Hunt KH, Resendez RG, Williams K et al.; San Antonio Heart Study. National Cholesterol Education program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004:110:1251-1257. (Pubitemid 39202341)
17. Tennenbaum A, Fisman EZ. "The metabolic syndrome.is dead": These reports are an exaggeration. Cardiovasc Diabetol 2011;10:11-14.